Featured news in The Life Sciences Report



Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Technological Innovation Pushes Bounds of Edible Cannabis Market (9/11/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
FDA Grants Orphan Drug Status to Acceleron's PAH Candidate (9/10/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast and Grunenthal Partner on Lower Back Pain Cell Therapy (9/10/2019)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China (9/10/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Corporate Update: Analyst Call (9/9/2019)

view
 

Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain (9/9/2019)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products (9/9/2019)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Earns $10 Million Milestone Payment for Further Development of a Long-Acting Injectable HIV Investigational Product Utilizing DURECT's SABER® Technology (9/9/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financial Officer (9/9/2019)

view